Literature DB >> 8461023

Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome.

T Kitamoto1, M Ohta, K Doh-ura, S Hitoshi, Y Terao, J Tateishi.   

Abstract

We found 3 novel missense variants in the open reading frame of the prion protein (PrP) gene. The codon 105 point mutation (proline to leucine) was found on a codon 129 (Valine) PrP allele in 4 patients from 3 different Japanese families with Gerstmann-Sträussler syndrome. The codon 180 variant PrP (valine to isoleucine) was found in Creutzfeldt-Jakob disease (CJD) patients with a similar clinical course to that of codon 178 mutation. The codon 232 variant PrP (methionine to arginine) was documented in the CJD patients with typical clinical and pathological findings. These variant PrP molecules were not detected in 200 normal Japanese PrP alleles. PrP has a large repertoire of variant forms, and each primary structure of PrP corresponds to the distinct phenotype of prion diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461023     DOI: 10.1006/bbrc.1993.1275

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Masanori Morita; Shusei Uno; Tetsuyuki Kitamoto
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

2.  α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.

Authors:  Atsushi Kobayashi; Tetsuya Hirata; Takashi Nishikaze; Akinori Ninomiya; Yuta Maki; Yoko Takada; Tetsuyuki Kitamoto; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2020-04-22       Impact factor: 5.157

3.  The prion protein gene in humans revisited: lessons from a worldwide resequencing study.

Authors:  Marta Soldevila; Aida M Andrés; Anna Ramírez-Soriano; Tomàs Marquès-Bonet; Francesc Calafell; Arcadi Navarro; Jaume Bertranpetit
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

Review 4.  Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions.

Authors:  Lyne Jossé; Ricardo Marchante; Jo Zenthon; Tobias von der Haar; Mick F Tuite
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 5.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

6.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

7.  Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutzfeldt-Jakob disease.

Authors:  T Muramoto; T Kitamoto; M Z Hoque; J Tateishi; I Goto
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Systematic investigation of predicted effect of nonsynonymous SNPs in human prion protein gene: a molecular modeling and molecular dynamics study.

Authors:  Samad Jahandideh; Degui Zhi
Journal:  J Biomol Struct Dyn       Date:  2013-03-25

9.  Ovine reference materials and assays for prion genetic testing.

Authors:  Michael P Heaton; Kreg A Leymaster; Theodore S Kalbfleisch; Brad A Freking; Timothy P L Smith; Michael L Clawson; William W Laegreid
Journal:  BMC Vet Res       Date:  2010-04-30       Impact factor: 2.741

10.  129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal.

Authors:  J C Manson; A R Clarke; M L Hooper; L Aitchison; I McConnell; J Hope
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.